Overview

CWI and Discharge After Breast Cancer Surgery

Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway
Details
Lead Sponsor:
University College Cork
Treatments:
Bupivacaine